1123741-50-3 Usage
General Description
1,3-Benzenedicarbonitrile, 5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]-, also known by its chemical structure C14H8FN3O, is a complex organic compound with a nitrile functional group and an indazole moiety. It has a molecular weight of 251.23 g/mol and is commonly used in pharmaceutical research and as a building block for the synthesis of various drugs. 1,3-Benzenedicarbonitrile, 5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]- has potential applications in the development of anticancer and antiviral medications due to its unique chemical structure and bioactivity. It is an important intermediate in the synthesis of novel compounds and is subject to ongoing research in the field of medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1123741-50-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,2,3,7,4 and 1 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1123741-50:
(9*1)+(8*1)+(7*2)+(6*3)+(5*7)+(4*4)+(3*1)+(2*5)+(1*0)=113
113 % 10 = 3
So 1123741-50-3 is a valid CAS Registry Number.
1123741-50-3Relevant articles and documents
Novel indazole non-nucleoside reverse transcriptase inhibitors using molecular hybridization based on crystallographic overlays
Jones, Lyn H.,Allan, Gill,Barba, Oscar,Burt, Catherine,Corbau, Romuald,Dupont, Thomas,Kn?chel, Thorsten,Irving, Steve,Middleton, Donald S.,Mowbray, Charles E.,Perros, Manos,Ringrose, Heather,Swain, Nigel A.,Webster, Robert,Westby, Mike,Phillips, Chris
experimental part, p. 1219 - 1223 (2010/01/07)
A major problem associated with non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of HIV is their lack of resilience to mutations in the reverse transcriptase (RT) enzyme. Using structural overlays of the known inhibitors efaviren